![]() | Only 14 pages are availabe for public view |
Abstract INTRODUCTION Hypertension is one of the major risk factors for coronary heart disease (CHD) according to epidemiologic st-c1dies (Gordon & Kannel 1 971; Rosenman et al., 1 97 6). It is perhaps the most readily treatable risk factor for CHD, either by hygienic meas’.lres or, ·when these are not eno-c1gh, by drug therapy (Culter 1 983). Based on favorable ratio between blood pressure lowering efficacy and known relative side ef~ects,diuretics are established as the major dr”.Jgs ln the -creatment of hypertension (Dustan et al., 1 974). Lately, the ·.1se of diuretics has been reco~~ended also for the treatment of ~he mildest =ar~s of hypertension, wit~ a view to avoiding the complications -chat may develop later in t~~e course of the disease ( C:Jl ter I 38 3). Yet a r..t::nber of large intervention ~rials nave failed to show any s”.Jbstantial benefit of blood pressure lowering on CHD :r,orta:’.i ty. In fact, according to the recent ~~ltiple Ris~ Factor Intervention Trial (C’iRFIT), C:!D :r.ortality did ~at decrease af~er stepped-care treatme~t of hypertenslOTI, counseling for c:.garette srr.cki:1g and dietary advice for lowering blood ’ ~ ..... ~ c.’1o_._es .__e:co.l.. .:.evels as co:npareci -with a siiilar population w~o received only their usual so~rces o:: ’clealth care in the community. 7his is in marked contrast - 2 - to the significant improvements in stroke, heart failure and renal failure that have been reported as a result of controlling high blood pressure (MRFIT 1 982). Because CHD is rsponsible for the largest number of deaths among patients with cardiovascular diseases, its lack of response mainly in on hypertension to diuretic drugs conventional therapy based consti t.u.::e a major proble:r. in cardiovas c:.1lar care (Ames 1 98 3) . The lack of impact of blood pressure lowering on CHD mortality has raised the question of whether the antihypertensive agents commonly used may be offsec:ting the potential benifit of such a reduction. The effect of di:.1retics on blood lipids and lipoproteins have been cited as a probable ca:.lse. Schoenfield and Goldberger ( 1 9 64) reported that serum cholesterol increased i:1 five of SlX cardiac patients treated with the thiazide diuretic bendroflumenthiazide and decreased when the drug was withdraw:1. This report was not widely acknowleged or co:1firned untill 1 97 6 when Arr.es a!1d 3ill have reported increases ir_ se::-:.:r!I cjolesterol of i 1 mg/dl and seru:n ::riglycerides increases o:’ 34 :rcg/dl ln patients treated with chlorthalido:1e. During the :’ollowlng 10 years, several workers studied the effects of diuretics on blood lipids and lipoproteins. Altho:.1gh their - 3 - results were not identical, yet the majority of these workers reported an increase in total cholesterol, total triglycerides, low density lipoprotein-cholesterol; together with a slight decrease in hig~ de:-:.si ty lipoprotein- cholesterol. These observations are of interest since epidemiological studies indicate that total cholesterol and low density lipoprotein-cholesterol concentra~ ions are positvely correlated with CHD risk; whereas, high density lipoprotein-cholesterol is negatively correlated with CHD risk (Gofman et al. 1 966, Slack 1 96 9, Kannel et al. 1971, carlson & Bottiger 1972, Stone et al. 1 974, ~!iller & !-Iiller 975, Castelli e~ al. 1 977, and Gordon et al. 1 977). There has been a growing use of i:1dices or ratios as indicatives of CHD risk, these are: total cholesterol 1’ high density lipoprotein-cholestero: a red low density lipoprote~n-choleste=ol / hig~ density :ipopro~ein-c~olesterol ratios (Castel~i e~ al. 1 977, Gordon et al. 1 977) . |